Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP1032 oral pilot study in moderate to severe chronic plaque psoriasis
2015-005159-28Phase 2Completed
- Sponsor
- MetrioPharm AG
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mp1032 in psoriasis, sponsored by MetrioPharm AG. Started Feb 2016; status: completed.
02
Drugs
mp1032
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2015-005159-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005159-28.